Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways

Clinical success of chimeric antigen receptor (CAR) T cell immunotherapy requires the engineering of autologous T cells, which limits the broader implementation of CAR cell therapy. The development of allogeneic and universal cell products will significantly broaden their application and reduce cost...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yan, Badeti, Saiaditya, Tseng, Hsiang-chi, Ma, Minh Tuyet, Liu, Ting, Jiang, Jie-Gen, Liu, Chen, Liu, Dongfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364029/
https://www.ncbi.nlm.nih.gov/pubmed/32695845
http://dx.doi.org/10.1016/j.omtm.2020.06.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364029/
https://www.ncbi.nlm.nih.gov/pubmed/32695845
http://dx.doi.org/10.1016/j.omtm.2020.06.014

Ejemplares similares